Mitochon Pharmaceuticals Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Cancelled)

  • Investors
  • 5

Mitochon Pharmaceuticals General Information

Description

Operator of a biotechnology platform intended to develop drugs that target the mitochondria for a host of severe diseases with significant unmet medical needs. The company's platform offers a pipeline of drugs that are designed to improve mitochondrial function and protect cells from damage, enabling customers to get the treatment they need for serious diseases that have limited treatment options.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • 970 Cross Lane
  • Blue Bell, PA 19422
  • United States
+1 (215) 000-0000

Mitochon Pharmaceuticals Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mitochon Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC Cancelled Clinical Trials - Phase 1
8. Secondary Transaction - Private 17-Feb-2023 00.000 Completed Clinical Trials - Phase 1
7. Grant 10-May-2022 00000 00.000 Completed Clinical Trials - Phase 1
6. Later Stage VC 13-Jul-2021 00.00 00.000 Completed Clinical Trials - Phase 1
5. Early Stage VC 30-Nov-2019 00.00 00.000 Completed Clinical Trials - Phase 1
4. Angel (individual) 21-Dec-2017 00000 00.000 Completed Pre-Clinical Trials
3. Grant 03-Oct-2017 000 00.000 Completed Pre-Clinical Trials
2. Early Stage VC 17-May-2016 $1.6M $2.35M Completed Pre-Clinical Trials
1. Early Stage VC 31-Mar-2015 $750K $750K Completed Pre-Clinical Trials
To view Mitochon Pharmaceuticals’s complete valuation and funding history, request access »

Mitochon Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology platform intended to develop drugs that target the mitochondria for a host of severe disease
Drug Discovery
Blue Bell, PA
4 As of 2024
00.000
00000 00000

000000

sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mi
0000 000000000
Cambridge, MA
00 As of 0000
0000
00000 0000-00-00
000000&0 0000

000000

nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Du
0000 000000000
New York, NY
00 As of 0000
00000
0000000000 0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mitochon Pharmaceuticals Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mitobridge Formerly VC-backed Cambridge, MA 00 0000 000000&0 0000
Volastra Venture Capital-Backed New York, NY 00 00000 0000000000 0 00000
G1 Therapeutics Formerly VC-backed Durham, NC 000 00000 00000000 00000
Epirium Bio Venture Capital-Backed San Diego, CA 00 000.00 00000000000 000.00
Ona Therapeutics Venture Capital-Backed Barcelona, Spain 00 0000 00000000000 0000
You’re viewing 5 of 17 competitors. Get the full list »

Mitochon Pharmaceuticals Patents

Mitochon Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10548900-B2 Dnp and dnp prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases Active 07-Mar-2016 00000000000 0
US-20200093831-A1 Dnp and dnp prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases Active 07-Mar-2016 00000000000
EP-3426233-A4 Dnp and dnp prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, concussion, dry eye disease, and/or metabolic diseases Pending 07-Mar-2016 000000000 0
EP-3426233-A1 Dnp and dnp prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, concussion, dry eye disease, and/or metabolic diseases Pending 07-Mar-2016 000000000
US-20170252347-A1 Dnp and dnp prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases Active 07-Mar-2016 A61K31/5375 0
To view Mitochon Pharmaceuticals’s complete patent history, request access »

Mitochon Pharmaceuticals Executive Team (6)

Name Title Board Seat
Robert Alonso Co-Founder, Chief Executive Officer & Board Member
John Geisler Ph.D Co-Founder , Chief Scientific Officer & Board Member
Marcus Keep MD Acting Chief Medical Officer
You’re viewing 3 of 6 executive team members. Get the full list »

Mitochon Pharmaceuticals Board Members (6)

Name Representing Role Since
Jennifer Hartt Ben Franklin Technology Partners of Southeastern Pennsylvania Board Member 000 0000
John Geisler Ph.D Mitochon Pharmaceuticals Co-Founder , Chief Scientific Officer & Board Member 000 0000
Robert Alonso Mitochon Pharmaceuticals Co-Founder, Chief Executive Officer & Board Member 000 0000
Sri Sriadibhatla Ph.D Ben Franklin Technology Partners of Southeastern Pennsylvania Board Observer 000 0000
Wolfgang Baiker MD Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Mitochon Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mitochon Pharmaceuticals Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Emily's Entourage Not-For-Profit Venture Capital 000 0000 000000 0
Cures Within Reach Corporation Minority 000 0000 000000 0
Michael J. Fox Foundation Limited Partner 000 0000 000000 0
Ben Franklin Technology Partners of Southeastern Pennsylvania Venture Capital Minority 000 0000 000000 0
YT Angels Angel Group Minority 000 0000 000000 0
To view Mitochon Pharmaceuticals’s complete investors history, request access »

Mitochon Pharmaceuticals FAQs

  • When was Mitochon Pharmaceuticals founded?

    Mitochon Pharmaceuticals was founded in 2014.

  • Who is the founder of Mitochon Pharmaceuticals?

    Robert Alonso and John Geisler Ph.D are the founders of Mitochon Pharmaceuticals.

  • Who is the CEO of Mitochon Pharmaceuticals?

    Robert Alonso is the CEO of Mitochon Pharmaceuticals.

  • Where is Mitochon Pharmaceuticals headquartered?

    Mitochon Pharmaceuticals is headquartered in Blue Bell, PA.

  • What is the size of Mitochon Pharmaceuticals?

    Mitochon Pharmaceuticals has 4 total employees.

  • What industry is Mitochon Pharmaceuticals in?

    Mitochon Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Mitochon Pharmaceuticals a private or public company?

    Mitochon Pharmaceuticals is a Private company.

  • What is Mitochon Pharmaceuticals’s current revenue?

    The current revenue for Mitochon Pharmaceuticals is 000000.

  • How much funding has Mitochon Pharmaceuticals raised over time?

    Mitochon Pharmaceuticals has raised $5.25M.

  • Who are Mitochon Pharmaceuticals’s investors?

    Emily's Entourage, Cures Within Reach, Michael J. Fox Foundation, Ben Franklin Technology Partners of Southeastern Pennsylvania, and YT Angels have invested in Mitochon Pharmaceuticals.

  • Who are Mitochon Pharmaceuticals’s competitors?

    Mitobridge, Volastra, G1 Therapeutics, Epirium Bio, and Ona Therapeutics are some of the 17 competitors of Mitochon Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »